Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 11, p. 1047, doi. 10.1002/cpdd.983
- Publication type:
- Article
Works matching IS 2160763X AND DT 2023 AND VI 12 AND IP 11
Results: 11
1
2
Pharmacokinetics and Drug–Drug Interaction of Allisartan Isoproxil and Indapamide Sustained‐Release Formulation.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 11, p. 1051, doi. 10.1002/cpdd.1321
- By:
- Publication type:
- Article
3
Pharmacokinetics and Pharmacodynamics of Burixafor Hydrobromide (GPC‐100), a Novel C‐X‐C Chemokine Receptor 4 Antagonist and Mobilizer of Hematopoietic Stem/Progenitor Cells, in Mice and Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 11, p. 1114, doi. 10.1002/cpdd.1302
- By:
- Publication type:
- Article
4
Bioequivalence of Two 6‐Mercaptopurine Tablet Formulations in Healthy Fasting Chinese Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 11, p. 1099, doi. 10.1002/cpdd.1298
- By:
- Publication type:
- Article
5
Bioequivalence of a Pediatric Fixed‐Dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Compared With Coadministration of the Separate Agents in Healthy Adults: An Open‐Label, Randomized, Replicate Crossover Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 11, p. 1060, doi. 10.1002/cpdd.1293
- By:
- Publication type:
- Article
6
Pharmacokinetic and Safety Study of Single and Multiple Oral Doses of Safinamide in Healthy Chinese Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 11, p. 1104, doi. 10.1002/cpdd.1277
- By:
- Publication type:
- Article
7
Bioequivalence of Celecoxib Capsules in Chinese Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 11, p. 1069, doi. 10.1002/cpdd.1270
- By:
- Publication type:
- Article
8
Pharmacokinetics of Nifedipine‐Sustained Release Tablets in Healthy Subjects After a Single Oral Administration: Bioequivalence Analysis and Food Effects.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 11, p. 1076, doi. 10.1002/cpdd.1269
- By:
- Publication type:
- Article
9
Bioequivalence Study of Miglitol Orally Disintegrating Tablets in Healthy Chinese Volunteers Under Fasting Condition Based on Pharmacodynamic and Pharmacokinetic Parameters.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 11, p. 1089, doi. 10.1002/cpdd.1268
- By:
- Publication type:
- Article
10
Pharmacokinetics, Safety, and Tolerability of Brivaracetam in Healthy Elderly Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 11, p. 1121, doi. 10.1002/cpdd.1264
- By:
- Publication type:
- Article
11
Pharmacokinetics and Bioequivalence of 2 Nifedipine Controlled‐Release Tablets: A Randomized, Single‐Dose, 2‐Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 11, p. 1082, doi. 10.1002/cpdd.1258
- By:
- Publication type:
- Article